30770 Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Rules and Regulations 

under the criteria of the Regulatory 

Flexibility Act. 

List of Subjects in 14 CFR Part 39 

Air transportation, Aircraft, Aviation 

safety, Incorporation by reference, 

Safety. 

The Amendment 

Accordingly, under the authority 

delegated to me by the Administrator, 

the FAA amends 14 CFR part 39 as 

follows: 

PART 39—AIRWORTHINESS 

DIRECTIVES 

■ 1. The authority citation for part 39 

continues to read as follows: 

Authority: 49 U.S.C. 106(g), 40113, 44701. 

§ 39.13 [Amended] 

■ 2. The FAA amends § 39.13 by adding 

the following new airworthiness 

directive: 

2021–11–13 Bell Textron Canada Limited: 

Amendment 39–21575; Docket No. 

FAA–2020–1170; Project Identifier 

MCAI–2020–00720–R. 

(a) Applicability 

This airworthiness directive (AD) applies 

to Bell Textron Canada Limited (Bell) Model 

429 helicopters, certificated in any category, 

with a Bell Emergency Flotation System 

(EFS) kit part number (P/N) 429–706–069– 

101/–103/–105/–121/–123/–125/–139/–141/– 

143/or –157 manufactured before July 2019, 

with a float supply hose manufactured before 

January 2014, installed, except for float 

supply hoses marked with ‘‘SB 025–69–21’’ 

above the external identification marking. 

(b) Unsafe Condition 

This AD defines the unsafe condition as a 

blocked float supply hose installed on an 

EFS. This condition could result in partial 

inflation of an EFS float during an emergency 

landing on water and subsequently 

preventing a timely egress from the 

helicopter. 

(c) Effective Date 

This AD is effective July 15, 2021. 

(d) Compliance 

You are responsible for performing each 

action required by this AD within the 

specified compliance time unless it has 

already been accomplished prior to that time. 

(e) Required Actions 

(1) Within 100 hours time-in-service (TIS): 

(i) Remove each EFS supply hose from the 

float and inspect each end of the EFS supply 

hose by inserting a plastic cable tie, 300 mm 

minimum × 5 mm maximum (11.811 in. 

minimum × .196 in. maximum), into the 

holes of the related fitting as shown in Figure 

1 of Safran Aerosystems Services Service 

Bulletin No. 025–69–21, Revision 00, dated 

March 23, 2020 (SB 025–69–21). 

Note 1 to paragraph (e)(1)(i): Each end of 

the supply hose may also be referred to as 

fitting or banjo. 

(ii) If the cable tie does not pass through 

the hose, before further flight, remove the 

EFS supply hose from service and replace it 

with an airworthy part. 

(iii) If the cable tie passes through the 

supply hose, mark a green dot with indelible 

ink on the base of the supply hose and write 

‘‘SB 025–69–21’’ above the external 

identification marking of the EFS with 

indelible ink. 

(2) As of the effective date of this AD, do 

not install an EFS supply hose manufactured 

before January 2014 on any helicopter unless 

the requirements in paragraph (e)(1) of this 

AD have been completed. 

(f) Alternative Methods of Compliance 

(AMOCs) 

(1) The Manager, International Validation 

Branch, FAA, has the authority to approve 

AMOCs for this AD, if requested using the 

procedures found in 14 CFR 39.19. In 

accordance with 14 CFR 39.19, send your 

request to your principal inspector or local 

Flight Standards District Office, as 

appropriate. If sending information directly 

to the manager of the International Validation 

Branch, send it to the attention of the person 

identified in paragraph (g)(1) of this AD. 

Information may be emailed to: 9-AVS-AIR730-AMOC@faa.gov. 

(2) Before using any approved AMOC, 

notify your appropriate principal inspector, 

or lacking a principal inspector, the manager 

of the local flight standards district office/ 

certificate holding district office. 

(g) Related Information 

(1) For more information about this AD, 

contact Matt Fuller, AD Program Manager, 

Operational Safety Branch, Airworthiness 

Products Section, General Aviation & 

Rotorcraft Unit, FAA, 10101 Hillwood Pkwy., 

Fort Worth, TX 76177; telephone 817–222– 

5110; email matthew.fuller@faa.gov. 

(2) The subject of this AD is addressed in 

Transport Canada AD CF–2020–212R1, dated 

August 19, 2020. You may view the 

Transport Canada AD on the internet at 

https://www.regulations.gov in Docket No. 

FAA–2020–1170. 

(h) Material Incorporated by Reference 

(1) The Director of the Federal Register 

approved the incorporation by reference of 

the service information listed in this 

paragraph under 5 U.S.C. 552(a) and 1 CFR 

part 51. 

(2) You must use this service information 

as applicable to do the actions required by 

this AD, unless the AD specifies otherwise. 

(i) Safran Aerosystems Services Service 

Bulletin No. 025–69–21, Revision 00, dated 

March 23, 2020 (SB 025–69–21). 

Note 2 to paragraph (h)(2)(i): SB 025–69– 

21 is attached to Bell Alert Service Bulletin 

No. 429–20–52, dated March 30, 2020, which 

is not incorporated by reference in this AD. 

(ii) [Reserved] 

(3) As the design approval holder for the 

product identified in paragraph (a) of this 

AD, contact Bell Textron Canada Limited for 

the Safran Aerosystems Services service 

information identified in this AD, at Bell 

Textron Canada Limited, 12,800 Rue de 

l’Avenir, Mirabel, Quebec J7J1R4; telephone 

450–437–2862 or 800–363–8023; fax 450– 

433–0272; or at https://

www.bellcustomer.com. 

(4) You may view this service information 

at the FAA, Office of the Regional Counsel, 

Southwest Region, 10101 Hillwood Pkwy., 

Room 6N–321, Fort Worth, TX 76177. For 

information on the availability of this 

material at the FAA, call (817) 222–5110. 

(5) You may view this service information 

that is incorporated by reference at the 

National Archives and Records 

Administration (NARA). For information on 

the availability of this material at NARA, 

email: fedreg.legal@nara.gov, or go to: 

https://www.archives.gov/federal-register/cfr/ 

ibr-locations.html. 

Issued on May 18, 2021. 

Lance T. Gant, 

Director, Compliance & Airworthiness 

Division, Aircraft Certification Service. 

[FR Doc. 2021–12042 Filed 6–9–21; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF TRANSPORTATION 

Federal Aviation Administration 

14 CFR Part 39 

[Docket No. FAA–2021–0187; Project 

Identifier AD–2020–01664–E; Amendment 

39–21583; AD 2021–11–21] 

RIN 2120–AA64 

Airworthiness Directives; CFM 

International, S.A. Turbofan Engines 

AGENCY: Federal Aviation 

Administration (FAA), DOT. 

ACTION: Final rule. 

SUMMARY: The FAA is adopting a new 

airworthiness directive (AD) for certain 

CFM International, S.A. (CFM) LEAP– 

1A model turbofan engines. This AD 

was prompted by a report of a 

manufacturing quality escape found 

during an inspection of a high-pressure 

turbine (HPT) case. This AD requires the 

removal from service of the affected 

HPT case. The FAA is issuing this AD 

to address the unsafe condition on these 

products. 

DATES: This AD is effective July 15, 

2021. 

The Director of the Federal Register 

approved the incorporation by reference 

of a certain publication listed in this AD 

as of July 15, 2021. 

ADDRESSES: For service information 

identified in this final rule, contact CFM 

International, S.A., Aviation Operations 

Center, 1 Neumann Way, M/D Room 

285, Cincinnati, OH 45125; phone: (877) 

432–3272; email: 

aviation.fleetsupport@ge.com. You may 

view this service information at the 

FAA, Airworthiness Products Section, 

Operational Safety Branch, 1200 District 


khammond on DSKJM1Z7X2PROD with RULES
Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Rules and Regulations 30771 

Avenue, Burlington, MA 01803. For 

information on the availability of this 

material at the FAA, call (781) 238– 

7759. It is also available at https://

www.regulations.gov by searching for 

and locating Docket No. FAA–2021– 

0187. 

Examining the AD Docket 

You may examine the AD docket at 

https://www.regulations.gov by 

searching for and locating Docket No. 

FAA–2021–0187; or in person at Docket 

Operations between 9 a.m. and 5 p.m., 

Monday through Friday, except Federal 

holidays. The AD docket contains this 

final rule, any comments received, and 

other information. The address for 

Docket Operations is U.S. Department of 

Transportation, Docket Operations, 

M–30, West Building Ground Floor, 

Room W12–140, 1200 New Jersey 

Avenue SE, Washington, DC 20590. 

FOR FURTHER INFORMATION CONTACT: 

Christopher McGuire, Aviation Safety 

Engineer, ECO Branch, FAA, 1200 

District Avenue, Burlington MA 01803; 

phone: (781) 238–7120; fax: (781) 238– 

7199; email: Chris.McGuire@faa.gov. 

SUPPLEMENTARY INFORMATION: 

Background 

The FAA issued a notice of proposed 

rulemaking (NPRM) to amend 14 CFR 

part 39 by adding an AD that would 

apply to certain CFM LEAP–1A23, 

LEAP–1A24, LEAP–1A24E1, LEAP– 

1A26, LEAP–1A26CJ, LEAP–1A26E1, 

LEAP–1A29, LEAP–1A29CJ, LEAP– 

1A30, LEAP–1A32, LEAP–1A33, LEAP– 

1A33B2, and LEAP–1A35A model 

turbofan engines. The NPRM published 

in the Federal Register on March 23, 

2021 (86 FR 15443). The NPRM was 

prompted by a report of a manufacturing 

quality escape found during an 

inspection of an HPT case. In the 

NPRM, the FAA proposed to require the 

removal from service of the affected 

HPT case. The FAA is issuing this AD 

to address the unsafe condition on these 

products. 

Discussion of Final Airworthiness 

Directive 

Comments 

The FAA received no comments on 

the NPRM or on the determination of 

the costs. 

Conclusion 

The FAA reviewed the relevant data 

and determined that air safety requires 

adopting this AD as proposed. 

Accordingly, the FAA is issuing this AD 

to address the unsafe condition on these 

products. This AD is adopted as 

proposed in the NPRM. 

Related Service Information Under 1 

CFR Part 51 

The FAA reviewed CFM Service 

Bulletin (SB) LEAP–1A–72–00–0421– 

01A–930A–D, Issue 001, dated October 

22, 2020. This SB specifies procedures 

for replacing the affected HPT cases. 

This service information is reasonably 

available because the interested parties 

have access to it through their normal 

course of business or by the means 

identified in ADDRESSES. 

Costs of Compliance 

The FAA estimates that this AD 

affects 8 engines installed on airplanes 

of U.S. registry. 

The FAA estimates the following 

costs to comply with this AD: 

ESTIMATED COSTS

Action Labor cost Parts cost Cost per 

product 

Cost on U.S. 

operators 

Remove and replace the HPT case ............... 1 work-hour × $85 per hour = $85 ................. $217,600 $217,685 $1,741,480 

Authority for This Rulemaking 

Title 49 of the United States Code 

specifies the FAA’s authority to issue 

rules on aviation safety. Subtitle I, 

section 106, describes the authority of 

the FAA Administrator. Subtitle VII: 

Aviation Programs, describes in more 

detail the scope of the Agency’s 

authority. 

The FAA is issuing this rulemaking 

under the authority described in 

Subtitle VII, Part A, Subpart III, Section 

44701: General requirements. Under 

that section, Congress charges the FAA 

with promoting safe flight of civil 

aircraft in air commerce by prescribing 

regulations for practices, methods, and 

procedures the Administrator finds 

necessary for safety in air commerce. 

This regulation is within the scope of 

that authority because it addresses an 

unsafe condition that is likely to exist or 

develop on products identified in this 

rulemaking action. 

Regulatory Findings 

This AD will not have federalism 

implications under Executive Order 

13132. This AD will not have a 

substantial direct effect on the States, on 

the relationship between the national 

government and the States, or on the 

distribution of power and 

responsibilities among the various 

levels of government. 

For the reasons discussed above, I 

certify that this AD: 

(1) Is not a ‘‘significant regulatory 

action’’ under Executive Order 12866, 

(2) Will not affect intrastate aviation 

in Alaska, and 

(3) Will not have a significant 

economic impact, positive or negative, 

on a substantial number of small entities 

under the criteria of the Regulatory 

Flexibility Act. 

List of Subjects in 14 CFR Part 39 

Air transportation, Aircraft, Aviation 

safety, Incorporation by reference, 

Safety. 

The Amendment 

Accordingly, under the authority 

delegated to me by the Administrator, 

the FAA amends 14 CFR part 39 as 

follows: 

PART 39—AIRWORTHINESS 

DIRECTIVES 

■ 1. The authority citation for part 39 

continues to read as follows: 

Authority: 49 U.S.C. 106(g), 40113, 44701. 

§ 39.13 [Amended] 

■ 2. The FAA amends § 39.13 by adding 

the following new airworthiness 

directive: 

2021–11–21 CFM International, S.A.: 

Amendment 39–21583; Docket No. 

FAA–2021–0187; Project Identifier AD– 

2020–01664–E. 

(a) Effective Date 

This airworthiness directive (AD) is 

effective July 15, 2021. 

(b) Affected ADs 

None. 

(c) Applicability 

This AD applies to CFM International, S.A. 

(CFM) LEAP–1A23, LEAP–1A24, LEAP– 

1A24E1, LEAP–1A26, LEAP–1A26CJ, LEAP– 

1A26E1, LEAP–1A29, LEAP–1A29CJ, LEAP– 

1A30, LEAP–1A32, LEAP–1A33, LEAP– 

1A33B2, and LEAP–1A35A model turbofan 

engines, with a high-pressure turbine (HPT) 

case, part number (P/N) 2668M94G01, that 


khammond on DSKJM1Z7X2PROD with RULES
30772 Federal Register / Vol. 86, No. 110 / Thursday, June 10, 2021 / Rules and Regulations 

contains a stage 7 port, P/N 2614M30P01, 

with a port casting serial number (S/N) listed 

in Table 1 in Planning Information, 

Paragraph 3.A., of CFM Service Bulletin (SB) 

LEAP–1A–72–00–0421–01A–930A–D, Issue 

001, dated October 22, 2020. 

(d) Subject 

Joint Aircraft System Component (JASC) 

Code 7250, Turbine Section. 

(e) Unsafe Condition 

This AD was prompted by a report of a 

manufacturing quality escape found during 

inspection of an HPT case. The FAA is 

issuing this AD to prevent failure of the HPT 

case. The unsafe condition, if not addressed, 

could result in failure of the HPT case, 

uncontained rotor release, damage to the 

engine, and damage to the airplane. 

(f) Compliance 

Comply with this AD within the 

compliance times specified, unless already 

done. 

(g) Required Actions 

Before the HPT case exceeds the cycles 

since new limit in Table 1, Planning 

Information, Paragraph 3.A., of CFM SB 

LEAP–1A–72–00–0421–01A–930A–D, Issue 

001, dated October 22, 2020, or during the 

next piece part exposure, whichever occurs 

first after the effective date of this AD, 

remove the affected HPT case from service 

and replace with a part eligible for 

installation. 

(h) Definitions 

For the purpose of this AD: 

(1) A part eligible for installation is an HPT 

case, P/N 2668M94G01, that contains a stage 

7 port, P/N 2614M30P01, with an S/N that 

is not listed in Table 1 in Planning 

Information, Paragraph 3.A., of CFM SB 

LEAP–1A–72–00–0421–01A–930A–D, Issue 

001, dated October 22, 2020. 

(2) Piece-part exposure is when the HPT 

case is removed from the engine and fully 

disassembled. 

(i) Alternative Methods of Compliance 

(AMOCs) 

(1) The Manager, ECO Branch, FAA, has 

the authority to approve AMOCs for this AD, 

if requested using the procedures found in 14 

CFR 39.19. In accordance with 14 CFR 39.19, 

send your request to your principal inspector 

or local Flight Standards District Office, as 

appropriate. If sending information directly 

to the manager of the certification office, 

send it to the attention of the person 

identified in Related Information. You may 

email your request to: ANE-AD-AMOC@

faa.gov. 

(2) Before using any approved AMOC, 

notify your appropriate principal inspector, 

or lacking a principal inspector, the manager 

of the local flight standards district office/ 

certificate holding district office. 

(j) Related Information 

For more information about this AD, 

contact Christopher McGuire, Aviation Safety 

Engineer, ECO Branch, FAA, 1200 District 

Avenue, Burlington, MA 01803; phone: (781) 

238–7120; fax: (781) 238–7199; email: 

Chris.McGuire@faa.gov. 

(k) Material Incorporated by Reference 

(1) The Director of the Federal Register 

approved the incorporation by reference 

(IBR) of the service information listed in this 

paragraph under 5 U.S.C. 552(a) and 1 CFR 

part 51. 

(2) You must use this service information 

as applicable to do the actions required by 

this AD, unless the AD specifies otherwise. 

(i) CFM Service Bulletin LEAP–1A–72–00– 

0421–01A–930A–D, Issue 001, dated October 

22, 2020. 

(ii) [Reserved] 

(3) For CFM service information identified 

in this AD, contact CFM International, S.A., 

Aviation Operations Center, 1 Neumann 

Way, M/D Room 285, Cincinnati, OH 45125; 

phone: (877) 432–3272; email: 

aviation.fleetsupport@ge.com. 

(4) You may view this service information 

at FAA, Airworthiness Products Section, 

Operational Safety Branch, 1200 District 

Avenue, Burlington, MA 01803. For 

information on the availability of this 

material at the FAA, call (781) 238–7759. 

(5) You may view this service information 

that is incorporated by reference at the 

National Archives and Records 

Administration (NARA). For information on 

the availability of this material at NARA, 

email: fedreg.legal@nara.gov, or go to: 

https://www.archives.gov/federal-register/cfr/ 

ibr-locations.html. 

Issued on May 21, 2021. 

Lance T. Gant, 

Director, Compliance & Airworthiness 

Division, Aircraft Certification Service. 

[FR Doc. 2021–12137 Filed 6–9–21; 8:45 am] 

BILLING CODE 4910–13–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

21 CFR Part 1308 

[Docket No. DEA–715] 

Schedules of Controlled Substances: 

Placement of Oliceridine in Schedule II 

AGENCY: Drug Enforcement 

Administration, Department of Justice. 

ACTION: Final rule. 

SUMMARY: This final rule adopts, with a 

change as mentioned below, an interim 

final rule with request for comments 

published in the Federal Register on 

October 30, 2020, placing oliceridine, N- 

[(3-methoxythiophen-2-yl)methyl]({2- 

[(9R)-9-(pyridin-2-yl)-6- 

oxaspiro[4.5]decan-9-yl]ethyl})amine 

fumarate, including its isomers, esters, 

ethers, salts and salts of isomers, esters 

and ethers whenever the existence of 

such isomers, esters, ethers and salts is 

possible, in schedule II of the Controlled 

Substances Act. In response to an error 

in the chemical name of oliceridine as 

noted by one of the commenters to the 

interim final rule, the Drug Enforcement 

Administration makes a correction to 

the above mentioned chemical name of 

oliceridine by removing the word 

‘‘fumarate’’ to read as N-[(3- 

methoxythiophen-2-yl)methyl]({2-[(9R)- 

9-(pyridin-2-yl)-6-oxaspiro[4.5]decan-9- 

yl]ethyl}amine. This change clarifies the 

control of oliceridine free base and its 

salts, to include the fumarate salt, by 

definition. 

DATES: Effective July 12, 2021. 

FOR FURTHER INFORMATION CONTACT: Dr. 

Terrence L. Boos, Drug and Chemical 

Evaluation Section, Diversion Control 

Division, Drug Enforcement 

Administration; Telephone: (571) 362– 

3249. 

SUPPLEMENTARY INFORMATION: 

Background and Legal Authority 

On October 30, 2020, the Drug 

Enforcement Administration (DEA), 

pursuant to 21 U.S.C. 811(j), published 

an interim final rule (IFR) to place 

oliceridine (including its isomers, 

esters, ethers, salts and salts of isomers, 

esters and ethers whenever the 

existence of such isomers, esters, ethers 

and salts is possible), a medication 

approved recently by the Food and Drug 

Administration (FDA) for medical use as 

an intravenous drug for the management 

of acute pain severe enough to require 

an intravenous opioid analgesic and for 

patients for whom alternative treatments 

are inadequate, in schedule II of the 

Controlled Substances Act (CSA). 85 FR 

68749. The IFR provided an opportunity 

for interested persons to submit 

comments, as well as file a request for 

hearing or waiver of hearing, on or 

before November 30, 2020. DEA 

received three comments and did not 

receive any requests for hearing or 

waiver of hearing. 

Comments Received 

In response to the IFR, DEA received 

three comments. The submissions were 

from individuals or anonymous 

commenters. One commenter suggested 

that oliceridine be placed in schedule III 

rather than schedule II, one commenter 

had a statement on the controlled name, 

and the third commenter discussed 

another substance entirely that was 

unrelated to oliceridine. As such, the 

third comment was outside the scope of 

this current scheduling action. 

Comment: One commenter suggested 

that oliceridine be placed in schedule III 

of the CSA, rather than schedule II. The 

commenter mentioned that placement of 

oliceridine in schedule II will limit its 

medical applications and limit access to 

the drug due to schedule II 

manufacturing quotas. The commenter 

stated that oliceridine has the potential 


khammond on DSKJM1Z7X2PROD with RULES